戻る Agenda
Session 3 – Part II: Update on International Activities and Collaboration – Focus on Africa
Session Chair(s)
Shahinaz Badr, PHARMD
Founder & Managing Director, Vigilance Gate FZ,LLC, United Arab Emirates
Elspeth McIntosh, MBA, RN
Director, Castle Pharmacovigilance Ltd, United Kingdom
This year's session will focus on international cooperation and joint collaboration between national and regional regulators, as well as international organizations. As examples we will look at the role of the Bill & Melinda Gates Foundation in advancing patient safety in Africa, hear updates on the development of the African Medicines Agency and learn more about the development of the QPPV role in an individual African country.
Speaker(s)
Chimwemwe Chamdimba
Principal Programme Officer-African Medicines Regulatory Harmonisation Program, African Union Development Agency-NEPAD, South Africa
Updates on the African Medicines Agency
Demeke Amare
Pharmacovigilance and Clinical Trial expert, Ethiopian Food and Drug Authority (EFDA), Ethiopia
EFDA: Ethiopia's Initiative on Training QPPVs
Deirdre McCarthy, MSC
Pharmacovigilance Lead, Regulatory System Strengthening, Gates Foundation, United States